Proprietary Pipeline
Proprietary Pipeline
Proprietary Pipeline
Modality
Project
Target
Indication
Discovery
Pre-clinical
IND-enabling
Phase-1
AR166
Undisclosed
Solid Tumor
Multi-Abkine
Multi-Abkine
AR169
Undisclosed
Solid Tumor
AR170
PD-1, VEGF,
IL receptor
Solid Tumor
pH-Dependent ADC
pH-Dependent ADC
B7-H3
Solid Tumor
PD-1
Solid Tumor
Monoclonal Antibody
Monoclonal Antibody
LAG-3
Solid Tumor
CD39
Solid Tumor
Next-generation Drug Pipeline
Immunoregulatory Monoclonal Antibodies
Modality
Project
Target
Indication
Discovery
Pre-clinical
IND-enabling
Phase-1
AR166
Undisclosed
Solid Tumor
Multi-Abkine
AR169
Undisclosed
Solid Tumor
AR170
PD-1, VEGF,
IL receptor
Solid Tumor
pH-Dependent ADC
B7-H3
Solid Tumor
PD-1
Solid Tumor
Monoclonal Antibody
LAG-3
Solid Tumor
CD39
Solid Tumor